Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) EPS (Weighted Average and Diluted): 2010-2025

Historic EPS (Weighted Average and Diluted) for Prestige Consumer Healthcare (PBH) over the last 16 years, with Mar 2025 value amounting to $4.29.

  • Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) fell 21.10% to $0.86 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.04, marking a year-over-year decrease of 1.70%. This contributed to the annual value of $4.29 for FY2025, which is 2.88% up from last year.
  • Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) amounted to $4.29 in FY2025, which was up 2.88% from $4.17 recorded in FY2024.
  • Over the past 5 years, Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) peaked at $4.29 during FY2025, and registered a low of -$1.65 during FY2023.
  • In the last 3 years, Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) had a median value of $4.17 in 2024 and averaged $2.27.
  • In the last 5 years, Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) crashed by 140.84% in 2023 and then soared by 352.73% in 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) (Yearly) stood at $3.25 in 2021, then rose by 24.31% to $4.04 in 2022, then crashed by 140.84% to -$1.65 in 2023, then spiked by 352.73% to $4.17 in 2024, then climbed by 2.88% to $4.29 in 2025.